Küpper, Charlotte
Stroth, Sanna
Wolff, Nicole
Hauck, Florian
Kliewer, Natalia
Schad-Hansjosten, Tanja
Kamp-Becker, Inge
Poustka, Luise
Roessner, Veit
Schultebraucks, Katharina http://orcid.org/0000-0001-5085-8249
Roepke, Stefan
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (FKZ 01EE1409A, FKZ 01EE1409A, FKZ 01EE1409A, FKZ 01EE1409A, FKZ 01EE1409A, FKZ 01EE1409A, FKZ 01EE1409A, FKZ 01EE1409A, FKZ 01EE1409A)
Deutsche Forschungsgemeinschaft (SCHU 3259/1-1)
Article History
Received: 17 October 2019
Accepted: 27 February 2020
First Online: 18 March 2020
Competing interests
: L.P. has received conference attendance support or speaking fees from Shire. She receives research funding by the BMBF, DFG and EU and royalties from Hogrefe, Kohlhammer and Schattauer. V.R. has received payment for consulting and writing activities from Lilly, Novartis, and Shire Pharmaceuticals, lecture honoraria from Lilly, Novartis, Shire Pharmaceuticals, and Medice Pharma, and support for research from Shire Pharmaceuticals and Novartis. He has carried out clinical trials in cooperation with the Novartis, Shire, Servier and Otsuka companies. The remaining authors declare that they have no competing interests.